Helius Medical Technologi... (HSDT)
0.59
-0.02 (-3.77%)
At close: Jan 28, 2025, 2:44 PM
undefined% (undefined)
| Bid | 0.59 |
| Market Cap | 2.20M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.27 |
| PE Ratio (ttm) | -0.14 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 0.61 |
| Volume | 182,856 |
| Avg. Volume (20D) | 4,829,876 |
| Open | 0.60 |
| Previous Close | 0.61 |
| Day's Range | 0.59 - 0.62 |
| 52-Week Range | 0.37 - 9.50 |
| Beta | undefined |
About HSDT
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic...
Industry Medical - Devices
Sector Healthcare
IPO Date Jun 27, 2014
Employees 22
Stock Exchange NASDAQ
Ticker Symbol HSDT
Website https://heliusmedical.com
Analyst Forecast
According to 2 analyst ratings, the average rating for HSDT stock is "Hold." The 12-month stock price forecast is $24, which is an increase of 3967.11% from the latest price.
Buy 50.00%
Hold 50.00%
Sell 0.00%
Next Earnings Release
Helius Medical Technologies Inc. is scheduled to release its earnings on Mar 27, 2025,
during market hours.
Analysts project revenue of $100.00K, reflecting a -25.37% YoY shrinking and earnings per share of -0.94, making a -36.05% decrease YoY.
Analysts project revenue of $100.00K, reflecting a -25.37% YoY shrinking and earnings per share of -0.94, making a -36.05% decrease YoY.
1 week ago
+37.15%
Helius Medical Technologies shares are trading hig...
Unlock content with
Pro Subscription
2 months ago
-6.64%
Helius Medical Technologies shares are trading lower after the company announced it initiated the process to explore a range of strategic alternatives.
